 Lumos Pharma, Inc. NASDAQ:LUMO Q2 2022 Earnings Conference Call August 9, 2022 4:30 PM ET Company Participants Lisa Miller - Senior Director of Investor Relations Richard Hawkins - Chairman and Chief Executive Officer Lori Lawley - Chief Financial Officer John McKew - President and Chief Scientific Officer David Karpf - Chief Medical Officer Conference Call Participants Charles Duncan - Cantor Fitzgerald, L.P Emma Nesson - Piper Sandler Co. Edward White - H.C. Wainwright Co, LLC Catherine Novack - Jones Research Leland Gershell - Oppenheimer Co. Inc. Elemer Piros - ROTH Capital Partners Operator Good afternoon, and welcome to Lumos Pharmas Second Quarter 2022 Results and Clinical Update Conference Call. 